181 related articles for article (PubMed ID: 8181289)
1. Increased plasma concentrations of soluble tumor necrosis factor receptors in sepsis syndrome: correlation with plasma creatinine values.
Froon AH; Bemelmans MH; Greve JW; van der Linden CJ; Buurman WA
Crit Care Med; 1994 May; 22(5):803-9. PubMed ID: 8181289
[TBL] [Abstract][Full Text] [Related]
2. Patterns of cytokines, plasma endotoxin, plasminogen activator inhibitor, and acute-phase proteins during the treatment of severe sepsis in humans.
Dofferhoff AS; Bom VJ; de Vries-Hospers HG; van Ingen J; vd Meer J; Hazenberg BP; Mulder PO; Weits J
Crit Care Med; 1992 Feb; 20(2):185-92. PubMed ID: 1371097
[TBL] [Abstract][Full Text] [Related]
3. sTREM-1 predicts intensive care unit and 28-day mortality in cancer patients with severe sepsis and septic shock.
Ravetti CG; Moura AD; Vieira ÉL; Pedroso ÊR; Teixeira AL
J Crit Care; 2015 Apr; 30(2):440.e7-13. PubMed ID: 25541104
[TBL] [Abstract][Full Text] [Related]
4. Immunological status of septic and trauma patients. I. High tumor necrosis factor alpha serum levels in septic and trauma patients are not responsible for increased mortality; a prognostic value of serum interleukin 6.
Adamik B; Zimecki M; Właszczyk A; Kübler A
Arch Immunol Ther Exp (Warsz); 1997; 45(2-3):169-75. PubMed ID: 9597083
[TBL] [Abstract][Full Text] [Related]
5. Circulating endothelin-1 and tumor necrosis factor-alpha: early predictors of mortality in patients with septic shock.
Brauner JS; Rohde LE; Clausell N
Intensive Care Med; 2000 Mar; 26(3):305-13. PubMed ID: 10823387
[TBL] [Abstract][Full Text] [Related]
6. Relationship of plasma leptin to plasma cytokines and human survivalin sepsis and septic shock.
Arnalich F; López J; Codoceo R; Jim nez M; Madero R; Montiel C
J Infect Dis; 1999 Sep; 180(3):908-11. PubMed ID: 10438392
[TBL] [Abstract][Full Text] [Related]
7. Early prediction of outcome in score-identified, postcardiac surgical patients at high risk for sepsis, using soluble tumor necrosis factor receptor-p55 concentrations.
Pilz G; Fraunberger P; Appel R; Kreuzer E; Werdan K; Walli A; Seidel D
Crit Care Med; 1996 Apr; 24(4):596-600. PubMed ID: 8612409
[TBL] [Abstract][Full Text] [Related]
8. Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome.
Casey LC; Balk RA; Bone RC
Ann Intern Med; 1993 Oct; 119(8):771-8. PubMed ID: 8379598
[TBL] [Abstract][Full Text] [Related]
9. Plasma cytokine determinations in emergency department patients as a predictor of bacteremia and infectious disease severity.
Moscovitz H; Shofer F; Mignott H; Behrman A; Kilpatrick L
Crit Care Med; 1994 Jul; 22(7):1102-7. PubMed ID: 8026198
[TBL] [Abstract][Full Text] [Related]
10. Inflammatory cytokine response in patients with septic shock secondary to generalized peritonitis.
Riché FC; Cholley BP; Panis YH; Laisné MJ; Briard CG; Graulet AM; Guéris JL; Valleur PD
Crit Care Med; 2000 Feb; 28(2):433-7. PubMed ID: 10708179
[TBL] [Abstract][Full Text] [Related]
11. Natural cytokine antagonists and endogenous antiendotoxin core antibodies in sepsis syndrome. The Sepsis Intervention Group.
Goldie AS; Fearon KC; Ross JA; Barclay GR; Jackson RE; Grant IS; Ramsay G; Blyth AS; Howie JC
JAMA; 1995 Jul; 274(2):172-7. PubMed ID: 7596007
[TBL] [Abstract][Full Text] [Related]
12. Cytokines, nitrite/nitrate, soluble tumor necrosis factor receptors, and procalcitonin concentrations: comparisons in patients with septic shock, cardiogenic shock, and bacterial pneumonia.
de Werra I; Jaccard C; Corradin SB; Chioléro R; Yersin B; Gallati H; Assicot M; Bohuon C; Baumgartner JD; Glauser MP; Heumann D
Crit Care Med; 1997 Apr; 25(4):607-13. PubMed ID: 9142024
[TBL] [Abstract][Full Text] [Related]
13. Plasma granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor levels in critical illness including sepsis and septic shock: relation to disease severity, multiple organ dysfunction, and mortality.
Presneill JJ; Waring PM; Layton JE; Maher DW; Cebon J; Harley NS; Wilson JW; Cade JF
Crit Care Med; 2000 Jul; 28(7):2344-54. PubMed ID: 10921563
[TBL] [Abstract][Full Text] [Related]
14. Cytokine serum level during severe sepsis in human IL-6 as a marker of severity.
Damas P; Ledoux D; Nys M; Vrindts Y; De Groote D; Franchimont P; Lamy M
Ann Surg; 1992 Apr; 215(4):356-62. PubMed ID: 1558416
[TBL] [Abstract][Full Text] [Related]
15. Perioperative TNF alpha and IL-6 concentrations correlate with septic state, organ function, and APACHE II scores in intra-abdominal infection.
Függer R; Zadrobilek E; Götzinger P; Klimann S; Rogy M; Winkler S; Andel H; Mittelböck M; Roth E; Schulz F
Eur J Surg; 1993 Oct; 159(10):525-9. PubMed ID: 8286509
[TBL] [Abstract][Full Text] [Related]
16. Serum tumor necrosis factor-alpha in neonatal sepsis.
Atici A; Satar M; Cetíner S; Yaman A
Am J Perinatol; 1997 Aug; 14(7):401-4. PubMed ID: 9263559
[TBL] [Abstract][Full Text] [Related]
17. Plasma kallistatin in critically ill patients with severe sepsis and septic shock.
Lin WC; Chen CW; Chao L; Chao J; Lin YS
PLoS One; 2017; 12(5):e0178387. PubMed ID: 28542440
[TBL] [Abstract][Full Text] [Related]
18. Does N-acetyl-L-cysteine influence cytokine response during early human septic shock?
Spapen H; Zhang H; Demanet C; Vleminckx W; Vincent JL; Huyghens L
Chest; 1998 Jun; 113(6):1616-24. PubMed ID: 9631802
[TBL] [Abstract][Full Text] [Related]
19. Patterns of cytokine evolution (tumor necrosis factor-alpha and interleukin-6) after septic shock, hemorrhagic shock, and severe trauma.
Martin C; Boisson C; Haccoun M; Thomachot L; Mege JL
Crit Care Med; 1997 Nov; 25(11):1813-9. PubMed ID: 9366763
[TBL] [Abstract][Full Text] [Related]
20. Plasma concentrations and anti-L-cytokine effects of alpha-melanocyte stimulating hormone in septic patients.
Catania A; Cutuli M; Garofalo L; Airaghi L; Valenza F; Lipton JM; Gattinoni L
Crit Care Med; 2000 May; 28(5):1403-7. PubMed ID: 10834686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
